{"id":"W1747781838","doi":"10.1001/jama.2015.4669","title":"Prevalence of Amyloid PET Positivity in Dementia Syndromes","year":2015,"lang":"en","type":"review","venue":"JAMA","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":666,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Institute on Aging; Health and Health Services Research Fund; Charles F. and Joanne Knight Alzheimer Disease Research Center, Washington University in St. Louis; Canadian Institutes of Health Research; University of California, San Diego; Pfizer; University of California, Los Angeles; AstraZeneca; European Commission; Genentech; National Institutes of Health; Région Normandie; University of Texas at Dallas; IXICO; Turun Yliopistollinen Keskussairaala; Medical Research Council; Servier; Universitat Autònoma de Barcelona; Universidad de Cantabria; Turun Yliopisto; Karolinska Institutet; Eisai; Dementia Collaborative Research Centres, Australia; Technische Universität München; Deutsche Forschungsgemeinschaft; Gentofte Hospital; Commonwealth Scientific and Industrial Research Organisation; Institut National de la Santé et de la Recherche Médicale; Bayer HealthCare; Center for Translational Molecular Medicine; Avid Radiopharmaceuticals; University of Pittsburgh; Washington University in St. Louis; Synarc; Imperial College London; Lui Che Woo Institute of Innovative Medicine; Northern California Institute for Research and Education; European Federation of Pharmaceutical Industries and Associations; Alzheimer's Association; F. Hoffmann-La Roche; Amorfix Life Sciences; Thomas Jefferson University; Biogen; BioClinica; University of Pennsylvania; Bristol-Myers Squibb; American Parkinson Disease Association; Janssen Alzheimer Immunotherapy Research And Development; Science and Industry Endowment Fund; National Health and Medical Research Council; Edith Cowan University; Medpace; Eli Lilly and Company; Alzheimer's Disease Neuroimaging Initiative; Meso Scale Diagnostics","keywords":"Medicine; Dementia; Amyloid (mycology); Pathology; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05697589382957914,"score_gpt":0.3867100868211052,"score_spread":0.3297341929915261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}